Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer Society. It typically causes no symptoms until it has already metastasized ...

In an early trial, a one-size-fits-all vaccine has shown promise in preventing the deadly pancreatic cancer from coming back. According to experts, this hard-to-treat cancer has a five-year survival ...

Medical researchers are celebrating after a vaccine is showing promising results in response to pancreatic cancer. Although it’s still in the early trial stage, this one-size-fits-all treatment could ...

A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies have failed in treating this deadly disease.

Advances in targeted therapies, especially those targeting KRAS mutations, and cancer vaccines show promise in pancreatic ...

The vaccine could be a game changer for Black people, who are disproportionately impacted by both cancers. According to the American Cancer Society, Black men and women have higher incidence rates and ...

Pancreatic cancer is hard to find early, which is why we are bringing attention to it on this World Pancreatic Cancer ...

Learn the subtle early signs of pancreatic dysfunction and cancer. Discover how early detection and advanced imaging can ...